Stockscreener 앱 받기
0.3862
3.43%
-0.0137
전일 마감가:
$0.3999
열려 있는:
$0.41
하루 거래량:
37,674
Relative Volume:
0.21
시가총액:
$6.10M
수익:
$1.84M
순이익/손실:
$-17.51M
주가수익비율:
-0.2789
EPS:
-1.3849
순현금흐름:
$-17.30M
1주 성능:
+1.05%
1개월 성능:
-22.11%
6개월 성능:
-51.43%
1년 성능:
-69.83%
1일 변동 폭
$0.3801
$0.41
1주일 범위
$0.3701
$0.41
52주 변동 폭
$0.3521
$1.35
Evogene Ltd Stock (EVGN) Company Profile
Compare EVGN vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVGN
Evogene Ltd
|
0.3862 | 6.10M | 1.84M | -17.51M | -17.30M | -1.3849 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-08 | 개시 | ROTH Capital | Buy |
| 2021-07-29 | 개시 | Aegis Capital | Buy |
| 2020-12-01 | 개시 | Cantor Fitzgerald | Overweight |
| 2013-12-16 | 개시 | Oppenheimer | Outperform |
Evogene Ltd 주식(EVGN)의 최신 뉴스
Weekly Recap: Board adds 2 and Pure withdraws offer, 60d standstill - TradingView
Form 13D/A Evogene Ltd. For: 11 October By Investing.com - Investing.com India
Form 13D/A Evogene Ltd. For: 11 October By Investing.com - Investing.com Canada
L.I.A. Pure Capital Submits 13D Amendment 7 Detailing Cooperation Agreement with Evogene Ltd. - Kalkine Media
Evogene reaches agreement with Pure Capital Group on board changes - Investing.com
Holders with 16.94% voting power strike a board deal with Evogene (EVGN). - Stock Titan
Holders of about 16.93% sign an Evogene (EVGN) deal that would reshape its board if approved. - Stock Titan
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors - PR Newswire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors - Moomoo
Pure Capital nominees could fill four of Evogene's seven board seats. - Stock Titan
Form 4 Evogene Ltd. For: 30 September By Investing.com - Investing.com Nigeria
Form 4 Evogene Ltd. For: 30 September By Investing.com - Investing.com Nigeria
Evogene Ltd. SEC Filing (Sep 30, 2026) - stocktitan.net
Director receives 2,500 options with a $0.58 exercise price from Evogene (EVGN). - stocktitan.net
Evogene Director Nir Nimrodi Awarded 10,000 Stock Options Under 2021 Incentive Plan - Kalkine Media
10,000 options with a $0.58 exercise price go to Evogene (EVGN) director Nir Nimrodi. - stocktitan.net
A director receives 2,500 Evogene (EVGN) stock options with a $0.58 exercise price. - stocktitan.net
Evogene receives 180-day extension for Nasdaq compliance - Investing.com
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance - PR Newswire
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance - PR Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
After about $2M in seed sales a year earlier, first-half revenue fell at Evogene (EVGN). - stocktitan.net
All 3,384,616 shares were sold; Evogene (EVGN) moves to end their resale registration. - stocktitan.net
Two Evogene (EVGN) directors resign amid investor claims over AGM vote - Stock Titan
L.I.A. Pure Capital Intends to Commence a Special Tender Offer to Evogene - marketscreener.com
Investor group in Evogene (NASDAQ: EVGN) plans a special tender offer under Israeli law - Stock Titan
8.6% Evogene (EVGN) holder bought 1.26M shares in August - Stock Titan
Casterra announces $2.2 Mn of purchase orders to supply castor seeds - AgroSpectrum India
Evogene Confirms Board Slate at September 4 Shareholder Meeting - TipRanks
Evogene Ltd. Approves Board Appointments - marketscreener.com
Evogene (EVGN) sets seven-member board after 2026 shareholder vote - Stock Titan
Evogene stock trades lower as biotech investors eye latest pipeline moves - AD HOC NEWS
L.I.A. Pure Capital Acquires 19.35% Activist Stake in Evogene (NASDAQ: EVGN) - Kalkine Media
L.I.A. Pure Capital Takes 19.35% Activist Stake in Evogene (NASDAQ: EVGN), Pushes for Board Changes - kalkinemedia.com
Evogene Ltd. (EVGN) stock price, news, quote and history - Yahoo Finance Australia
Evogene urges shareholders to support current b... - pluang.com
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - TradingView
Evogene stock holds steady as investors eye latest genomics progress - ad-hoc-news.de
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - PR Newswire
Evogene (EVGN) investor group pushes for board seats at annual meeting - Stock Titan
[6-K] Evogene Ltd. Current Report (Foreign Issuer) - Stock Titan
Evogene Updates U.S. Investors With New August 2026 Presentation - TipRanks
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com India
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com Canada
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com UK
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees - PR Newswire
Evogene Ltd (EVGN) Stock News Today - tradingkey.com
Evogene (EVGN) Momentum: Ends Higher by 3.14% at $0.60 on the Day; Next Session: $0.57 and $0.63 Define the Nearby Reference Levels for the Current SessionMoney Flow - dars.gov.et
Evogene (EVGN) Momentum: Ends Higher by 3.14% at $0.60 on the Day; Next Session: $0.57 and $0.63 Define the Nearby Reference Levels for the Current SessionDay Trade Opportunities - vinanet.vn
Evogene Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Evogene Ltd (EVGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Evogene Ltd 주식 (EVGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RECANATI LEON | Director |
Aug 11 '26 |
Buy |
0.64 |
460,000 |
292,100 |
1,343,886 |
| RECANATI LEON | Director |
Aug 04 '26 |
Buy |
0.50 |
800,000 |
400,000 |
883,886 |
4.22%
자본화:
|
볼륨(24시간):